Article
Lymph node dissection plays expanding role in urology
Less than 20 years ago, lymphadenectomy and lymph node dissection were primarily used as staging procedures. Today, studies have shown that the procedures can increase the survival rates in patients with a host of urologic cancers. In this exclusive interview, Urs Studer, MD, professor and chairman of the department of urology, University of Bern, Switzerland, discusses the expanding role of lymph node dissection in bladder, prostate, and kidney cancer. The interview was conducted by UT Editorial Consultant Robert C. Flanigan, MD, professor and chairman of the department of urology at Loyola University Medical Center, Maywood, IL.
Related Videos
Laura Davis, MD, on link between microplastics and bladder cancer
Roger Dmochowski, MD, on real-world persistence with vibegron for OAB
NMIBC Maintenance Therapy: Timing, Dosing, and Follow-Up
BRCA Mutations in mHSPC: Impact on Therapy Selection
Formulations, Food, and Frequency: Optimizing Absorption and Tolerability in Daily Practice
Defining and Managing BCG-Unresponsive NMIBC
Considerations for patient follow-up after onabotA administration
Mitchell Huang, MD, on the link between obesity and pain on transperineal biopsy
Administering onabotA: Improving patient comfort and easing anxiety
Yahir A. Santiago-Lastra, MD, discusses barriers to vaginal estrogen access
Related Content
